Mobile technology, wireless monitoring systems, RFID. LIMS and electronic notebook systems. Automation, QBAS, & process analytical technology. Service-oriented architecture & integration. Risk management and CAPA.
September 21, 2011
By:
Kristie J. Diebold
Equipment and Processing Report
Glass flaking or delamination can result in a failed quality-assurance test, thus bringing production to a halt and causing substantial revenue loss. If glass delamination remains undiscovered, it can pose a serious contamination risk to the drug product and a potential health risk to the public.
|
September 15, 2011
By:
Erik Greb
ePT--the Electronic Newsletter of Pharmaceutical Technology
The International Society for Pharmaceutical Engineering will soon publish an update for its guide to sterile-product manufacturing facilities. The new publication will replace the original guide and contain practical information about technological advances in sterile manufacturing.
|
September 2, 2011
By:
Hallie Forcinio
Pharmaceutical Technology
Smartphones could become the product-authentication tool of choice. Contains online bonus material.
|
August 17, 2011
By:
Justin Neway
Equipment and Processing Report
Using information technology tools to enhance process understanding helps reduce variability that can affect speed to market.
|
August 1, 2011
By:
James Wright, Malcolm Horsley
Pharmaceutical Technology
Manufacturers are facing ever-increasing competition while end users are expecting better value and efficacy. The authors discuss these challenges and offer practical solutions.
|
|
August 1, 2011
By:
Adam Sherlock
Pharmaceutical Technology Europe
Companies know they need regulatory information management, but they don't always know where to start and how to weave this capability across diverse technology applications.
|
June 30, 2011
By:
Erik Greb
ePT--the Electronic Newsletter of Pharmaceutical Technology
President Obama unveiled an Advanced Manufacturing Partnership designed to reinvigorate the country's manufacturing sector.
|
June 23, 2011
By:
Stephanie Sutton
The Association of the British Pharmaceutical Industry (ABPI) has published a guidance that suggests best practices for managing adverse events and other pharmacovigilance data from the internet and social media tools.
|
|
